About PrecisionMed
PrecisionMed is a Healthcare company based in San Diego (United States) founded in 1996, and was acquired by BioIVT in July 2023. It operates as a human biological materials for research are supplied via a biorepository. PrecisionMed offers products and services including CSF Samples, Serum and Plasma Products, Liquid Biopsy, and FFPE Tissue. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Biorepository. Its legal entity is PrecisionMed, LLC. Its competitors include GenVault Corporation, iSpecimen, Cryoniss, AminoChain and ViaCell and 2 more; 5 of its 7 listed competitors have raised funding.
Company details
PrecisionMed was established in 1996 in San Diego, United States, within the biotechnology sector focused on research support. A biorepository of annotated human biological samples is operated, including longitudinally collected cerebrospinal fluid from normal and diseased individuals. Serum, other body fluids, FFPE tissues, slides, and wet tissues are also provided. Normal control samples, termed TruNormal, are sourced through a network of partner institutions and matched to diseased materials as needed.
- Headquarters San Diego, United States
- Stage Acquired
- SectorsHealthcare
- Phone•••• ••••
- Website precisionmed.com
- Social LinkedIn Facebook
- Acquired by BioIVT (Jul 2023)
- Legal Name Precisionmed, Llc
Products & Services of PrecisionMed
PrecisionMed offers a comprehensive portfolio of products and services, including CSF Samples, Serum and Plasma Products, Liquid Biopsy, and FFPE Tissue.
Human CSF for longitudinal research with matched clinical data.
Human serum and plasma for biomarker discovery and diagnostics.
Samples for oncology research and molecular diagnostics.
Formalin-fixed paraffin-embedded tissue for genetic studies.
Funding Insights of PrecisionMed
- Total Rounds 1
- Last Round Unspecified — $1.22M
- First Round $1.22M
(Feb 2014)
All 1 funding rounds of PrecisionMed with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2014 | $1.22M | Unspecified | – | – | – |
2 investors in total: 2 institutional.
Investors in PrecisionMed
PrecisionMed has secured backing from 2 investors. Prominent investors backing the company include BioIVT and West-Atlantic Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Invests in and partners with private businesses in healthcare, telecom, and technology. | 2019 | west-atlanticpartners.com | San Diego, United States | |
Provider of in vitro diagnostic products and assay services | 2015 | bioivt.com | Westbury, United States |
Investor details for PrecisionMed
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of PrecisionMed
5 people are tracked at PrecisionMed (2 in leadership, 3 in team).
| Name | Role | Group |
|---|---|---|
Renee Gruber | Director of Marketing | Leadership |
Tracy Wilkie | Sr. CRM, Project Director | Leadership |
Judy McCoy | Sr Accountant | Team |
Jake Fely | Inventory Manager | Team |
Kristin Knickerbocker | Site Leader | Team |
Complete people profiles for PrecisionMed
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of PrecisionMed
4 dated milestones of PrecisionMed across 27 years, from founding to its latest funding, stage changes and deals.
- Founded PrecisionMed is founded.
- Funding First funding round of $1.2M.
- Exit Acquired by West-Atlantic Partners.
- Exit Acquired by BioIVT.
Competitors of PrecisionMed
PrecisionMed has 7 listed competitors in our database, 5 of them funded. They include GenVault Corporation, iSpecimen, Cryoniss, AminoChain and ViaCell, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| genvault.com | 2000 | Carlsbad, United States | $47.8M | – | Biosamples are stabilized, transported, stored, and retrieved by GenVault. | |
| ispecimen.com | 2009 | Lexington, United States | $11.86M | 75 | Provider of a biorepository of human clinical specimens | |
| cryoniss.com | 2018 | Macclesfield, United Kingdom | $683,055 | 9 | Provider of biobanking services for life sciences industries | |
| aminochain.io | 2022 | New York, United States | $7.07M | – | A blockchain-based platform for tokenizing and incentivizing stem cell donations | |
| viacellinc.com | 1994 | Cambridge, United States | $63M | – | Provider of services for collecting and preserving umbilical cord blood stem cells | |
| cryoportinc.com | 2019 | Brentwood, United States | – | 1,170 | Supply chain solutions for cell and gene therapies are provided. | |
| clean-cells.com | 2000 | Bouffere, France | – | – | Offers cell banking and virus banking services |
Detailed competitors of PrecisionMed
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of PrecisionMed
The website of PrecisionMed (precisionmed.com) receives about 1.1K visits a month.
- Monthly visits1.1K
▼ 50.2% vs previous month
Top companies in Life Sciences Platforms & Tools
10 companies that operate in the same segment as PrecisionMed (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | 1,111 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Precisionmed
Complete news archive for PrecisionMed
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PrecisionMed
PrecisionMed was founded in 1996 and raised its 1st funding round 18 years after it was founded.
PrecisionMed is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
PrecisionMed was established in 1996 in San Diego, United States, within the biotechnology sector focused on research support. A biorepository of annotated human biological samples is operated, including longitudinally collected cerebrospinal fluid from normal and diseased individuals. Serum, other body fluids, FFPE tissues, slides, and wet tissues are also provided. Normal control samples, termed TruNormal, are sourced through a network of partner institutions and matched to diseased materials as needed.
PrecisionMed's top competitors include Cryoport, iSpecimen and Clean Cells.
PrecisionMed offers CSF Samples, Serum and Plasma Products, Liquid Biopsy, and FFPE Tissue.
PrecisionMed has 2 investors. Key investors include BioIVT, and West-Atlantic Partners.
PrecisionMed operates through Precisionmed, Llc.
Yes. PrecisionMed was acquired by BioIVT in July 2023.